All Products are stable to be shipped at room temperature, unless otherwise specified.
| Pack Size | Quantity | Price (USD) | Sub Total |
|---|---|---|---|
| 5mg | $ 65.00 | 0.0 | |
| 10mg | $ 100.00 | 0.0 | |
| 25mg | $ 225.00 | 0.0 | |
| 50mg | $ 410.00 | 0.0 | |
| 100mg | $ 800.00 | 0.0 | |
| 250mg | $ 1740.00 | 0.0 | |
| Exact Weight Packaging | $ 145.00 | 0.0 | |
| Total | $ 0.0 | ||
Product successfully added to cart.
- Request another packsize ? Click here.
- Inventory Status : Currently Back Ordered - Please Request Lead Time
- Ships On :
A108485
Bulk Order Request for A108485
Product Description
| Catalogue Number | A108485 |
| Chemical Name | Abiraterone 3-((1-Chloroethyl)sulfinyl)benzene |
| Synonyms | (8R,9S,10R,13S,14S)-3-(1-Chloro-1-(phenylsulfinyl)ethyl)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,6,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; |
| Molecular Formula | C₃₂H₃₈ClNO₂S |
| Appearance | Beige Solid |
| Molecular Weight | 536.17 |
| Solubility | Dichloromethane, Ethyl Acetate, Methanol |
| Category | Standards; Chiral Molecules; Steroids; Pharmaceutical/API Drug Impurities/Metabolites; |
| Applications | Abiraterone 3-((1-Chloroethyl)sulfinyl)benzene is an intermediate in synthesizing 3-Deoxy-3-acetylabiraterone-3-ene (D232060), which is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| References | Denis, L., et al.: Cancer, 72, 3888 (1993); |